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Damage ﬁrst; infect later
 
ike a picky tourist looking for a hotel room, the malaria-
causing protozoan 
 
Plasmodium
 
 passes through several 
cells before settling on one to infect. Margarida Carrolo, 
Maria Mota (Instituto Gulbenkian de Ciência, Oeiras, Portugal), 
and colleagues now report that the initial invasions cause 
the damaged cells to make a factor that primes other cells 
for infection.
The factor turned up in culture medium from infected or 
wounded cells. When added to uninfected cells, this condi-
tioned medium doubled the level of infection. The factor 
was identified as hepatocyte growth factor (HGF), which is 
made by hepatocytes in response to wounding. Those cells 
that were permeable to dextran (because of 
 
Plasmodium
 
-
induced wounding) were the same ones that made HGF.
Mota earlier showed that the passage through cells primes 
 
Plasmodium
 
 for infection. Once it is primed, 
 
Plasmodium
 
 
induces a folding of the plasma membrane that becomes a 
parasitophorous vacuole. The Portugese group noted HGF-
induced changes in the actin cytoskeleton in hepatocytes, 
and they speculate that these changes may be necessary 
for early parasite development.
 
 
 
The HGF receptor Met 
is not a receptor for 
 
Plasmodium
 
, but when 
the group inhibited Met’s 
kinase activity this did 
prevent 
 
Plasmodium
 
 
infection, even when 
the inhibition occurred after invasion. Any such treatment 
“needs to be prophylactic, because people don’t know they 
are infected at this stage,” says Mota. She is contacting 
companies that are developing anti-cancer drugs targeting 
Met, and also hopes to find other targets downstream of 
Met activation.
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Damaged, dextrin-permeable cells 
(green) make HGF (red).
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Latching onto ﬁbrinogen
 
bacterial adhesin grabs hold of its extracellular matrix target, 
then covers it and latches the compartment shut, according 
to two structures determined by Karthe Ponnuraj, Sthanam Narayan  A 
 
(University of Alabama, Birmingham, AL), Magnus Hook 
Fibrinogen (purple) is 
latched in place when the 
G” strand crosses from N3 
(yellow) to N2 (green).
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But this is no simple binding 
event. The presence of the peptide, 
found the researchers, induces con-
formational changes in a COOH-
terminal region of SdrG that previously 
extended out from the protein’s N3 
domain to wave in the wind. After 
peptide binding, the region now 
extends over the peptide, thus forming 
a hydrogen-bonded roof, and then 
inserts into a 
 
 
 
-sheet in the adjacent 
N2 domain.
The latch may be far from unique. 
The region in N2 that receives the latching 
 
 
 
 strand makes up a 
motif that is present in many other gram-positive bacterial adhesins. 
These proteins, which are used by bacteria that replicate extracellularly, 
“are all like extending velcros,” says Narayan, “but there is specificity.” 
For SdrG, the binding also covers the thrombin-cleavage site in 
fibrinogen. This prevents the formation of fibrinopeptides that can 
act as chemoattractants for leukocytes and fibroblasts. 
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Cell.
 
 115:217–228.
 
How to renew a stem cell
 
he unique cell cycle characteristics of 
stem cells are defined, at least in part, 
by a polycomb transcription factor called 
Bmi-1, according to Anna Molofsky, 
Ricardo Pardal, Sean Morrison, and 
colleagues (University of Michigan, Ann 
Arbor, MI). Bmi-1 is unique because, 
unlike other important cell cycle proteins 
such as Myc, it is needed in stem cells but 
not in their offspring. Thus, it is important 
as much for what it is not as for what it is.
The loss of Bmi-1, the researchers find, 
leaves mice deficient in stem cell capacity. 
The mice survive using only restricted 
progenitor cells that are limited in both the 
types of cells that they can generate and 
the numbers of divisions in which they 
T
 
can do so. The resulting depletion in cells 
leads to growth and neurological defects, 
and early death.
Earlier work had established that Bmi-1, 
via its repression of the cell cycle inhibitor 
p16, is required for the proliferation of 
Stem cells lacking Bmi-1 proliferate poorly.
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found that the cause was reduced prolif-
eration rather than increased cell death. 
But after differentiation factors were 
added, the difference disappeared. Now, 
both cells with and without Bmi-1 con-
tinued to proliferate.
There are two situations in which an 
explanation requires more than just Bmi-1 
and p16. Prenatally, something other than 
Bmi-1 must be capable of repressing p16 
expression. In the restricted progenitors, 
meanwhile, Bmi-1 is no longer needed 
because the cell cycle is now insensitive to 
elevated levels of p16. Future studies will 
be focused on understanding this difference 
in sensitivity, and testing downstream of 
Bmi-1 for pathways unrelated to p16.
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hematopoietic stem cells (HSCs). The 
Michigan group found a similar phenom-
enon with stem cells in the central 
nervous system, at least after birth, and 
 
(Texas A&M, Houston, TX), and colleagues.
The first structure, of the unbound SdrG 
protein from 
 
Staphylococcus epidermis,
 
 shows 
a wide cleft between two immunoglobulin-
like domains. This cleft is the binding site
for a peptide from the extracellular matrix 
protein fibrinogen.
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